Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lumeng Jenny Yu"'
Autor:
Rafal Goraczniak, Brian A Wall, Mark A Behlke, Kim A Lennox, Eric S Ho, Nikolas H Zaphiros, Christopher Jakubowski, Neil R Patel, Steven Zhao, Carlo Magaway, Stacey A Subbie, Lumeng Jenny Yu, Stephanie LaCava, Kenneth R Reuhl, Suzie Chen, Samuel I Gunderson
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 2, Iss C (2013)
U1 Adaptor is a recently discovered oligonucleotide-based gene-silencing technology with a unique mechanism of action that targets nuclear pre-mRNA processing. U1 Adaptors have two distinct functional domains, both of which must be present on the sam
Externí odkaz:
https://doaj.org/article/05875fbc03754cd9bb797287478d6134
Autor:
Jairo Sierra, Robert Cerchio, James S. Goydos, Lumeng Jenny Yu, Ho Chung Chen, Brian A. Wall, Suzie Chen
Publikováno v:
Oncotarget
Our laboratory previously showed that ectopic expression of Grm1 is sufficient to induce spontaneous melanoma formation with 100% penetrance in transgenic mouse model, TG-3, which harbors wild-type BRaf. Studies identified Grm1 expression in human me
Publikováno v:
Journal of the American College of Surgeons. 231:S171
Autor:
Lumeng Jenny Yu, Nataliya Parobchak, Max Rosen, Kseniya Gololobova, Mary Nguyen, Adriana A. T. Martin, Todd Rosen, Bingbing Wang
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
The non-canonical NF-κB signaling (RelB/p52) pathway drives pro-labor genes in the human placenta, including corticotropin-releasing hormone (CRH) and cyclooxygenase-2 (COX-2), making this a potential therapeutic target to delay onset of labor. Here
Autor:
Samuel I. Gunderson, Kim A. Lennox, Stephanie LaCava, Lumeng Jenny Yu, Carlo Magaway, Christopher D Jakubowski, Suzie Chen, Stacey A Subbie, Rafal Goraczniak, Steven Zhao, Brian A. Wall, Mark A. Behlke, Eric S. Ho, Neil Patel, Kenneth R. Reuhl, Nikolas H Zaphiros
Publikováno v:
Molecular Therapy. Nucleic Acids
Molecular Therapy: Nucleic Acids, Vol 2, Iss C (2013)
Molecular Therapy: Nucleic Acids, Vol 2, Iss C (2013)
U1 Adaptor is a recently discovered oligonucleotide-based gene-silencing technology with a unique mechanism of action that targets nuclear pre-mRNA processing. U1 Adaptors have two distinct functional domains, both of which must be present on the sam